Sign in
4

Changes in Ownership

Kura Oncology, Inc. Filed Acc 0001209191-21-048540

Options or other derivatives

  • Director acquired 65,166 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Collins Helen Louise · Director

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-07-28 Grant or award : show line 1 in the form Option to purchase common stock +46,000 $18.98 2031-07-27 46,000 46,000 D
2021-07-28 Grant or award : show line 2 in the form Option to purchase common stock +19,166 $18.98 2031-07-27 19,166 19,166 D
Loading xslF345X03/doc4.xml…